Sniffing out an alternative: WVU scientists developing nasal mist vaccine targeting COVID-19
Heath Damron and his colleagues at WVU are continuing to evaluate the nasal mist vaccine against currently circulating strains including the delta variant. The team is looking for commercial partners to help facilitate production at scale and further clinical evaluation.